In the clinical finding, the high expression of CD94+ cells increased the survival rate in the nasal-type extranodal NK/T-cell lymphoma patients [42] or inhibited leukocytes-activation-induced apoptosis [41]. This evidence concerns the gene KLRD1 and T-cell non-Hodgkin lymphoma.